BRAINTREE, Mass., Aug. 29, 2016 /PRNewswire/ -- Haemonetics Corporation (NYSE:HAE) announced that Gerry
Gould, Vice President – Investor Relations, will present at The Baird 2016 Global Healthcare Conference in New York on Thursday, September 8, 2016 at 3:10pm
The public may access Mr. Gould's presentation live via webcast at http://wsw.com/webcast/baird46/hae.
Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative hematology products and solutions for our customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit our web site at http://www.haemonetics.com.
INVESTOR CONTACT:Gerry Gould, VP-Investor Relations(781) firstname.lastname@example.org
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/haemonetics-to-present-at-the-baird-2016-global-healthcare-conference-300319518.html
Subscribe to our Free Newsletters!
Nissen fundoplication is an acid reflux surgical procedure used to treat gastro-esophageal reflux ...
Myelodysplastic syndromes are a group of bone marrow stem cell disorders marked by ineffective ...
Endoscopic Retrograde Cholangio-Pancreatography uses endoscopy and fluoroscopic imaging for ...View All